Kontigo Care publishes Q2 2026 interim report with financial results
Revenue rises 1.8% to 7.2 MSEK while EBITDA turns positive at 0.8 MSEK. The firm advances US expansion and prepares for October product launch.
See the latest news and media coverage for Kontigo Care. We track all announcements, press releases, and industry mentions in real time, all in one place.
Digital addiction, mental health, and workplace safety platform
kontigocare.comLast updated
In short: Kontigo Care reported positive EBITDA for Q2 2026, advanced its US expansion, and strengthened its AI-based drug testing portfolio.
Revenue rises 1.8% to 7.2 MSEK while EBITDA turns positive at 0.8 MSEK. The firm advances US expansion and prepares for October product launch.
The board was re-elected with a new chairman, no dividend is paid, and the board is authorized to issue shares.
The board proposes re-election of Johan Fagerlund Sjöberg and authorization for issuance of up to 10% of the shares.
MRR increased to 2.35 MSEK and net sales to 7.4 MSEK. Operating result improved to 0.2 MSEK. Pilot study for Previct® Safety is initiated and Peter Larsson assumes the role as CFO.
Kontigo Care, active with digital tools within addiction care, reports an operating result of minus 1.1 million SEK (minus 1.4) for the...
Kontigo Care AB Annual stock financials by MarketWatch. View the latest 3KT financial statements, income statements and financial ratios.
Kontigo Care AB Annual stock financials by MarketWatch. View the latest KONT financial statements, income statements and financial ratios.
In its plans, KONTIGO bets on building a technological hub in Caracas, which compresses all the company's learnings during its time in Silicon...
Track Kontigo Care and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.